Walmart and Sam’s Club pharmacies are collaborating with the U.S. Federal Retail Pharmacy Therapeutics Program to release COVID antiviral medications Paxlovid and Molnupiravir starting Thursday (Dec. 30).
Only those with a prescription from a health care provider are able to obtain the medication.
“We are committed to working with our state and federal partners to provide access to new treatment options like authorized COVID-19 antiviral medications, as they become available,” said Kevin Host, senior vice president of pharmacy. “This offers customers the option to recover at home and helps reduce the burden on our hospitals and communities.”
“Worst Decision in Its History”: Scientists Baffled by FDA Authorization of Merck’s Experimental COVID-19 Pill
The FDA recently issued emergency use authorization to a Merck’s experimental COVID-19 treatment. Called molnupiravir, the new drug is not as effective as Pfizer’s recently approved COVID antiviral pill, and many experts warn the FDA should never have authorized it due to the potential for generating new SARS-CoV-2 variants. Read more
Pfizer’s New COVID-19 Pill Could Cause Serious Interactions With Widely Used Prescriptions, Experts Warn
Many people prescribed Pfizer’s new COVID-19 pill will require careful monitoring by doctors because it may not be safe for everyone, experts have warned.
